Shockwave Medical Inc (NASDAQ:SWAV)
| 263.92 Delayed Data As of Nov 25 |  -0.14 / -0.05%Today’s Change | 113.36 Today|||52-Week Range 320.54 | +48.00% Year-to-Date |
Latest SWAV News | Press Releases
Today’s Trading
| Previous close | 264.06 |
| Today’s open | 264.06 |
| Day’s range | 261.63 - 264.88 |
| Volume | 4,236 |
| Average volume (3 months) | 500,140 |
| Market cap | $9.0B |
Data as of 1:00pm ET, 11/25/2022
Growth & Valuation
| Earnings growth (last year) | +86.89% |
| Earnings growth (this year) | +1,243.64% |
| Earnings growth (next 5 years) | +111.00% |
| Revenue growth (last year) | +249.83% |
| P/E ratio | 111.8 |
| Price/Sales | 26.39 |
| Price/Book | 36.61 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TFXTeleflex Inc | -0.21 | -0.09% |
| PENPenumbra Inc | +0.24 | +0.12% |
| ---- | ||
| IARTIntegra Lifesciences... | +0.31 | +0.58% |
Data as of 1:00pm ET, 11/25/2022
Financials
| Next reporting date | February 16, 2023 |
| EPS forecast (this quarter) | $0.99 |
| Annual revenue (last year) | $237.1M |
| Annual profit (last year) | -$9.1M |
| Net profit margin | -3.85% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Santa Clara, California |
Forecasts
